Abstract
The purpose of this analysis was to evaluate the technological viability, basic safety and consequence of central pancreatectomy (CP) with pancreaticogastrostomy in properly chosen sufferers with noncancerous central pancreatic pathology. This research is centered on the infirmary charts of West China hospital. We recruited 20 individuals from 2007 to 2009 diagnosed with benign cancerous growth of pancreatic body and neck. They underwent pancreatic body and neck resection adhering to pancreaticogastrostomy. We carried out central pancreatectomy following pancreaticogastrostomy in 20 patients: 8 with serous cyst adenomas, 11 with mucinous cystadenomas, and 1 with neuroendocrine tumor. The position of all tumors was restricted to body and neck of the pancreas, measuring a mean ± standard deviation of 2.6±1.3cm. The mean post-operative hospital stay was 7 days (ranging from 6 to 16 days).There was no intraoperative additional complications. From a technical perspective, CP is a safe and sound, pancreas-preserving pancreatectomy for non-enucleable non-cancerous pancreatic pathology restricted to the pancreatic body.
Highlights
Benign lesions of the neck and proximal body of the pancreas offer a problematic operative obstacle
In the current study, basic safety of PG was predominantly based on technological factors of the pancreaticogastric anastomosis
Watanabe et al publicized in the Japan Pancreas Surgery Group survey of 511 pancreaticogastrostomy and 2483 pancreaticojejunostomy patients
Summary
Benign lesions of the neck and proximal body of the pancreas offer a problematic operative obstacle. Pancreaticogastrostomy (PG) has been explored in the last several years as a substitute renovation approach when compared with pancreaticojejunostomy (PJ), being encouraged by quite a few experts [1,2]. Delcore et al revealed a procedure of PG in which 2 to 3 cm of the pancreatic remnant was telescoped into the gastric lumen. They revealed 0% incidence of pancreatic fistula following this approach [3]. Numerous prospective benefits of PG have been formerly endorsed. They incorporate the deterrence of pancreatic enzyme activation by gastric acidity and technological facets associated to the vicinity of the pancreas to the gastric wall and diminished anastomosis in a single jejunal loop.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
